These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

809 related articles for article (PubMed ID: 26363004)

  • 1. Paracrine Engineering of Human Cardiac Stem Cells With Insulin-Like Growth Factor 1 Enhances Myocardial Repair.
    Jackson R; Tilokee EL; Latham N; Mount S; Rafatian G; Strydhorst J; Ye B; Boodhwani M; Chan V; Ruel M; Ruddy TD; Suuronen EJ; Stewart DJ; Davis DR
    J Am Heart Assoc; 2015 Sep; 4(9):e002104. PubMed ID: 26363004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new direction for cardiac regeneration therapy: application of synergistically acting epicardium-derived cells and cardiomyocyte progenitor cells.
    Winter EM; van Oorschot AA; Hogers B; van der Graaf LM; Doevendans PA; Poelmann RE; Atsma DE; Gittenberger-de Groot AC; Goumans MJ
    Circ Heart Fail; 2009 Nov; 2(6):643-53. PubMed ID: 19919990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracrine Engineering of Human Explant-Derived Cardiac Stem Cells to Over-Express Stromal-Cell Derived Factor 1α Enhances Myocardial Repair.
    Tilokee EL; Latham N; Jackson R; Mayfield AE; Ye B; Mount S; Lam BK; Suuronen EJ; Ruel M; Stewart DJ; Davis DR
    Stem Cells; 2016 Jul; 34(7):1826-35. PubMed ID: 27059540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis-Resistant Cardiac Progenitor Cells Modified With Apurinic/Apyrimidinic Endonuclease/Redox Factor 1 Gene Overexpression Regulate Cardiac Repair After Myocardial Infarction.
    Aonuma T; Takehara N; Maruyama K; Kabara M; Matsuki M; Yamauchi A; Kawabe J; Hasebe N
    Stem Cells Transl Med; 2016 Aug; 5(8):1067-78. PubMed ID: 27334489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined intramyocardial delivery of human pericytes and cardiac stem cells additively improves the healing of mouse infarcted hearts through stimulation of vascular and muscular repair.
    Avolio E; Meloni M; Spencer HL; Riu F; Katare R; Mangialardi G; Oikawa A; Rodriguez-Arabaolaza I; Dang Z; Mitchell K; Reni C; Alvino VV; Rowlinson J; Livi U; Cesselli D; Angelini G; Emanueli C; Beltrami AP; Madeddu P
    Circ Res; 2015 May; 116(10):e81-94. PubMed ID: 25801898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells overexpressing GCP-2 improve heart function through enhanced angiogenic properties in a myocardial infarction model.
    Kim SW; Lee DW; Yu LH; Zhang HZ; Kim CE; Kim JM; Park TH; Cha KS; Seo SY; Roh MS; Lee KC; Jung JS; Kim MH
    Cardiovasc Res; 2012 Sep; 95(4):495-506. PubMed ID: 22886775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice.
    Chimenti I; Smith RR; Li TS; Gerstenblith G; Messina E; Giacomello A; Marbán E
    Circ Res; 2010 Mar; 106(5):971-80. PubMed ID: 20110532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-1 receptor identifies a pool of human cardiac stem cells with superior therapeutic potential for myocardial regeneration.
    D'Amario D; Cabral-Da-Silva MC; Zheng H; Fiorini C; Goichberg P; Steadman E; Ferreira-Martins J; Sanada F; Piccoli M; Cappetta D; D'Alessandro DA; Michler RE; Hosoda T; Anastasia L; Rota M; Leri A; Anversa P; Kajstura J
    Circ Res; 2011 Jun; 108(12):1467-81. PubMed ID: 21546606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined administration of mesenchymal stem cells overexpressing IGF-1 and HGF enhances neovascularization but moderately improves cardiac regeneration in a porcine model.
    Gómez-Mauricio G; Moscoso I; Martín-Cancho MF; Crisóstomo V; Prat-Vidal C; Báez-Díaz C; Sánchez-Margallo FM; Bernad A
    Stem Cell Res Ther; 2016 Jul; 7(1):94. PubMed ID: 27423905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolyl hydroxylase domain protein 2 silencing enhances the survival and paracrine function of transplanted adipose-derived stem cells in infarcted myocardium.
    Wang WE; Yang D; Li L; Wang W; Peng Y; Chen C; Chen P; Xia X; Wang H; Jiang J; Liao Q; Li Y; Xie G; Huang H; Guo Y; Ye L; Duan DD; Chen X; Houser SR; Zeng C
    Circ Res; 2013 Jul; 113(3):288-300. PubMed ID: 23694817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory peptides from cardiac progenitors ameliorate dysfunction after myocardial infarction.
    Liu ML; Nagai T; Tokunaga M; Iwanaga K; Matsuura K; Takahashi T; Kanda M; Kondo N; Naito AT; Komuro I; Kobayashi Y
    J Am Heart Assoc; 2014 Dec; 3(6):e001101. PubMed ID: 25468657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous transplantation of endothelial progenitor cells genetically modified by adeno-associated viral vector delivering insulin-like growth factor-1 gene after myocardial infarction.
    Sen S; Merchan J; Dean J; Ii M; Gavin M; Silver M; Tkebuchava T; Yoon YS; Rasko JE; Aikawa R
    Hum Gene Ther; 2010 Oct; 21(10):1327-34. PubMed ID: 20497036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway.
    Lin M; Liu X; Zheng H; Huang X; Wu Y; Huang A; Zhu H; Hu Y; Mai W; Huang Y
    Stem Cell Res Ther; 2020 Jan; 11(1):22. PubMed ID: 31918758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction.
    Padin-Iruegas ME; Misao Y; Davis ME; Segers VF; Esposito G; Tokunou T; Urbanek K; Hosoda T; Rota M; Anversa P; Leri A; Lee RT; Kajstura J
    Circulation; 2009 Sep; 120(10):876-87. PubMed ID: 19704095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts.
    Lou X; Zhao M; Fan C; Fast VG; Valarmathi MT; Zhu W; Zhang J
    Cardiovasc Res; 2020 Mar; 116(3):671-685. PubMed ID: 31350544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expandable human cardiovascular progenitors from stem cells for regenerating mouse heart after myocardial infarction.
    Schwach V; Gomes Fernandes M; Maas S; Gerhardt S; Tsonaka R; van der Weerd L; Passier R; Mummery CL; Birket MJ; Salvatori DCF
    Cardiovasc Res; 2020 Mar; 116(3):545-553. PubMed ID: 31287499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Intracoronary Infusion of Escalating Doses of Cardiac Stem Cells in Rats With Acute Myocardial Infarction.
    Tang XL; Rokosh G; Sanganalmath SK; Tokita Y; Keith MC; Shirk G; Stowers H; Hunt GN; Wu W; Dawn B; Bolli R
    Circ Heart Fail; 2015 Jul; 8(4):757-65. PubMed ID: 25995227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategic advantages of insulin-like growth factor-I expression for cardioprotection.
    Chao W; Matsui T; Novikov MS; Tao J; Li L; Liu H; Ahn Y; Rosenzweig A
    J Gene Med; 2003 Apr; 5(4):277-86. PubMed ID: 12692862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed enrichment for c-kit and inducing cardiac differentiation attenuated protective effects of BMSCs' transplantation in pig model of acute myocardial ischemia.
    Zhang GW; Gu TX; Guan XY; Sun XJ; Jiang DQ; Tang R; Qi X; Li XY
    Cardiovasc Ther; 2015 Aug; 33(4):184-92. PubMed ID: 25959676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximizing ventricular function with multimodal cell-based gene therapy.
    Yau TM; Kim C; Li G; Zhang Y; Weisel RD; Li RK
    Circulation; 2005 Aug; 112(9 Suppl):I123-8. PubMed ID: 16159803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.